WuXi Vaccines' Drug Substance Facility Receives Brazil ANVISA GMP Certification for Dengue Vaccine Manufacturing
SUZHOU, China, May 26, 2026 /PRNewswire/ -- WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today that its drug substance facility (MFG23) located...
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic color
This positive CHMP opinion is based on results from the Phase 3 BREAKWATER trial, which showed that encorafenib in combination with cetuximab and mFOLFOX6 demonstrated a statistically significant improvement in the dual primary endpoints of...
Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease
Congenital adrenal hyperplasia (CAH) and Cushing's disease (CD) are rare disorders characterized by excess adrenocorticotropic hormone (ACTH) produced in the brain1,2 Current treatments are limited by suboptimal disease control and treatment-related...
Citi Singapore receives dual award recognition from FinanceAsia and Forbes
Citi named Best International Bank and Best International Investment Bank in Singapore by FinanceAsia for the second year in a row Citi ranked as #1 in Singapore among Forbes World's Best Banks 2026 SINGAPORE, April 27, 2026 /PRNewswire/ -- Citi...
SK hynix receives 2026 IEEE Corporate Innovation Award for Driving AI Computing Expansion with HBM
SK hynix honored at the 2026 IEEE Awards for leading AI technology innovation with HBM Contributed to the global AI computing ecosystem via stable mass production across all HBM generations Company committed to becoming a premier leader in AI...
PRESIDENT SAMIA RECEIVES COMMISSION OF INQUIRY REPORT; CALLS FOR NATIONAL HEALING, ACCOUNTABILITY AND REFORMS
DAR ES SALAAM, Tanzania, April 24, 2026 /PRNewswire/ -- Her Excellency Dr. Samia Suluhu Hassan, President of the United Republic of Tanzania today received the Report of the Presidential Commission of Inquiry into the events of violence and breach...
4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union
In a separate announcement made today, the Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion. MELBOURNE, Australia, March 31, 2026 /PRNewswire/ -- 4DMedical Limited (ASX:4DX),...
Arnold Schwarzenegger receives Honorary Doctorate from Ulster University
Global screen icon, former Governor of California, Emmy-winning producer and seven-time Mr Olympia recognised for his contributions to public service, environmental action and the arts BELFAST, Northern Ireland , March 31, 2026 /PRNewswire/ --...
Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy
SHANGHAI, March 13, 2026 /PRNewswire/ -- On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the U.S....
XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult patients with multiple myeloma (MM). - In South Korea, XPOVIO® has been approved for three...